EUVIMEDEUVIMED entdecken
Crossref

Analysis of Immunometabolic Profiles in Patients With Chronic Drug‐Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms

Xingran Zhai, Xian He, Ang Huang, Zherui Liu, Shaoting Chen, Binxia Chang, Yun Zhu, Huan Xie, Zhaofang Bai iD, Xiaohe Xiao, Ying Sun, Jiabo Wang iD und 2 weitere

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.16876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Xingran Zhai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Peking University 302 Clinical Medical School, Beijing, China. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Chronic, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The mechanism underlying chronic drug‐induced liver injury (DILI) remains unclear. Immune activation is a common feature of DILI progression and is closely associated with metabolism. We explored the immunometabolic profile of chronic DILI and the potential mechanism of chronic DILI progression.

Methods

Plasma and peripheral blood mononuclear cells from patients with chronic DILI were analyzed using multiplex immunoassays and untargeted metabolomics to reveal their immunometabolic profile. The effects and potential mechanisms of chronic DILI‐related metabolite on acute or chronic liver injury induced by LPS or CCl 4 in mice were investigated.

Results

Patients with chronic DILI exhibited elevated plasma IL‐6, IL‐12p70, IL‐15 and reduced IL‐10 levels. The percentage of IL‐12 + monocytes was higher, while that of CD206 + monocytes, IL‐10 + monocytes, Th2, Treg, and IL‐10 + CD4 + T cells were lower in patients with chronic DILI compared to those with acute DILI. We identified the most significantly increased metabolite in patients with chronic DILI was cis‐aconitic acid (CAA). Administration of CAA can attenuate liver injury in mice with acute liver injury induced by LPS or CCl 4 and promote the spontaneous resolution of liver fibrosis in mice with chronic live injury induced by CCl 4 . The protective mechanism of CAA against liver injury is associated with the inhibition of hepatic macrophage infiltration and polarization, which is achieved by inhibiting the secretion of neutrophil‐derived IL‐33 and subsequent phosphorylation of GATA3.

Conclusions

CAA, which is elevated in patients with chronic DILI, protects against liver injury by inhibiting hepatic macrophage infiltration and polarization through the suppression of the IL‐33/GATA3 pathway, suggesting that CAA may serve as a potential target for regulating tissue repair in liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver Injury, ChronicChemical and Drug Induced Liver InjuryAnimalsHumansMaleFemaleMiddle AgedDisease Models, AnimalMetabolomicsMiceMice, Inbred C57BLCytokinesAdultLeukocytes, MononuclearDisease Progression

Stichwörter der Autor:innen

chronicitycis‐aconitic aciddrug‐induced liver injuryimmunologymacrophagesmetabolism

Substanzen

Cytokines

Autor:innen und Institutionen

  • Peking University 302 Clinical Medical School, Beijing, China.
  • School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Department of Gastroenterology and Hepatology, the First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Senior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, China.

ORCID-Profile: Zhaofang Bai, Jiabo Wang, Zhengsheng Zou

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing
  • Beijing Nova Program

Zitieren

APA

Zhai, X., He, X., Huang, A., Liu, Z., Chen, S., Chang, B., Zhu, Y., Xie, H., Bai, Z., Xiao, X., Sun, Y., Wang, J., Lu, Y., & Zou, Z. (2025). Analysis of Immunometabolic Profiles in Patients With Chronic Drug‐Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16876

Vancouver

Zhai X, He X, Huang A, Liu Z, Chen S, Chang B, et al. Analysis of Immunometabolic Profiles in Patients With Chronic Drug‐Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16876

BibTeX
@article{Zhai2025,
  author = {Zhai, Xingran and He, Xian and Huang, Ang and Liu, Zherui and Chen, Shaoting and Chang, Binxia and Zhu, Yun and Xie, Huan and Bai, Zhaofang and Xiao, Xiaohe and Sun, Ying and Wang, Jiabo and Lu, Yawen and Zou, Zhengsheng},
  title = {Analysis of Immunometabolic Profiles in Patients With Chronic Drug‐Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.16876}
}
Kostenlos starten →